Details

Current status of newborn screening in Southeastern and Central Europe
ID Požun, Nika (Author), ID Perko, Daša (Author), ID Anastasovska, Violeta (Author), ID Battelino, Tadej (Author), ID Drole Torkar, Ana (Author), ID Mlinarič, Matej (Author), ID Remec, Žiga Iztok (Author), ID Repič-Lampret, Barbka (Author), ID Trampuž, Domen (Author), ID Žerjav-Tanšek, Mojca (Author), ID Grošelj, Urh (Author), et al.

.pdfPDF - Presentation file, Download (534,63 KB)
MD5: 22DB9D4E3D0460A7DDA31ABAEE4EF399
URLURL - Source URL, Visit https://www.mdpi.com/2409-515X/12/1/14 This link opens in a new window

Abstract
Newborn screening (NBS) is a well-established public health program that enables early detection and treatment of rare disorders in newborns, preventing severe complications or death. Despite its recognized importance, the scope and implementation of NBS programs vary across Southeastern (SE) and Central Europe. This study aimed to evaluate the current status of NBS in 16 countries of SE and Central Europe and assess progress since the previous survey in 2021. A structured questionnaire was distributed to national experts between April and December 2025, collecting data on program organization, coverage, diseases included, laboratory methods, confirmatory testing, consent practices, and future expansion plans. All countries reported universal screening for congenital hypothyroidism, except Kosovo, where a national NBS is in the process of being established. Expanded NBS using tandem mass spectrometry was available in Austria, Bulgaria, Croatia, Cyprus, Greece, Hungary, North Macedonia, Romania, and Slovenia. Spinal muscular atrophy screening became universal in Austria, Croatia, Hungary, Serbia, and Slovenia. Most countries reported plans for further expansion, with congenital adrenal hyperplasia, severe combined immunodeficiency, spinal muscular atrophy, and cystic fibrosis being the most frequently targeted conditions. Although notable infrastructural progress has been achieved, financial constraints, lack of staff, and organizational barriers remain key challenges. The study’s assessment of program effectiveness was further limited by the absence of region-wide systems for capturing end-to-end performance indicators, such as the age of the infant at treatment initiation or missed cases. Regional collaboration and adoption of best practices are therefore vital to ensure equitable access and continuous advancement of NBS programs.

Language:English
Keywords:newborn screening, NBS, Southeastern Europe, Central Europe, neonatal screening, expanded NBS program
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2026
Number of pages:23 str.
Numbering:Vol. 12, issue 1, art. 14
PID:20.500.12556/RUL-183381 This link opens in a new window
UDC:616-053.2
ISSN on article:2409-515X
DOI:10.3390/ijns12010014 This link opens in a new window
COBISS.SI-ID:270681603 This link opens in a new window
Publication date in RUL:12.06.2026
Views:90
Downloads:73
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:International journal of neonatal screening
Shortened title:Int. j. neonatal screen.
Publisher:MDPI
ISSN:2409-515X
COBISS.SI-ID:525322521 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0343
Name:Etiologija, zgodnje odkrivanje in zdravljenje bolezni pri otrocih in mladostnikih

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back